Remote Monitoring of Cardiac Implantable Electronic Devices

Introduction to Remote Monitoring

Remote monitoring of cardiac implantable electronic devices (CIEDs) operates through a scheduled transmission system rather than continuous real-time monitoring, as recommended by the American College of Cardiology 1
Remote pacemaker devices do not monitor patients continuously but rather transmit data at predetermined intervals or when triggered by specific alerts, according to the American College of Cardiology 1

Data is typically sent at predetermined intervals, every 3-12 months for pacemakers and every 3-6 months for ICDs/CRTs, as stated by the American College of Cardiology 1
Devices are programmed to send automatic alerts for specific clinically significant events such as abnormal battery voltage, abnormal lead parameters, and increased duration or frequency of arrhythmia episodes, according to the American College of Cardiology 1

Contemporary systems use bidirectional telemetry with encrypted radiofrequency signals, and information is transmitted to a central server where clinicians can access it via the internet, as described by the American College of Cardiology 1 and further explained in Circulation 2
Many systems use wireless cellular technology to extend telemetry links into the patient's location, as noted by the American College of Cardiology 1 and Circulation 2

Remote monitoring provides comprehensive device information similar to in-office visits, including battery voltage and status, charge time, percentage of pacing, sensing thresholds, and stored arrhythmia events with electrograms, as stated by the American College of Cardiology 1
Remote monitoring has demonstrated significant benefits, including early detection of clinically actionable events, decreased time to clinical decision, fewer required office visits, and comparable long-term survival rates to in-person monitoring, according to the American College of Cardiology 1 and reported in Circulation 2

The American College of Cardiology/American Heart Association/Heart Rhythm Society guidelines recommend initial in-person evaluation within 72 hours of implantation, follow-up in-person evaluation at 2-12 weeks post-implantation, and subsequent monitoring can be done remotely or in-person according to the recommended schedule, with annual in-person evaluation until battery depletion, as stated by the American College of Cardiology 1
The guidelines recommend remote monitoring protocols, including remote transmissions at predetermined intervals, typically every 3-12 months for pacemakers and 3-6 months for ICDs/CRTs, with automatic alerts programmed to flag critical events, and data is transmitted to a central server where it can be accessed by clinicians 1, 2
Patient activation is allowed in some systems, where patients can manually trigger transmissions for clinical reasons between scheduled intervals, as noted by the American College of Cardiology 1
Critical alerts are typically reviewed during regular business hours, with a focus on scheduled transmissions and automatic alerts rather than continuous real-time monitoring, as recommended by the American College of Cardiology 1 and Circulation 2